Clinical Trial Update: Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

View source ↗

Summary

This clinical trial update describes ongoing monitoring of pregnancy and infant outcomes after exposure to tralokinumab during pregnancy in the United States an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: University of California, San Diego | Conditions: Atopic Dermatitis, Eczema | Status: RECRUITING